Pembrolizumab for PD-L1–Positive Breast Cancer Refractory to Chemotherapy

Phan, Kim DO; Charif, Mahmoud MD

American Journal of Therapeutics: June 18, 2019 - Volume Publish Ahead of Print - Issue - p

doi: 10.1097/MJT.0000000000001015

Letters to the Editor: PDF Only

BUY

PAP

• Author Information
• Article Metrics

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.